Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nu Holdings
NU
|
+$91.9M |
| 2 |
SW
Smurfit Westrock plc
SW
|
+$76.1M |
| 3 |
Pinduoduo
PDD
|
+$30.9M |
| 4 |
Microsoft
MSFT
|
+$24.9M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$22.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$122M |
| 2 |
Apple
AAPL
|
+$45.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$29M |
| 5 |
Flutter Entertainment
FLUT
|
+$20.3M |
Sector Composition
| 1 | Technology | 32.64% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.2% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Kforce
KFRC
$583M
| $2.22M | ﹤0.01% |
36,200
-300
| -0.8% | -$18.4K |
|
1802
Winmark
WINA
$1.82B
| $2.22M | ﹤0.01% |
5,800
-100
| -2% | -$38.3K |
|
1803
Alignment Healthcare
ALHC
$3.24B
| $2.22M | ﹤0.01% |
187,600
| – | – |
|
1804
Sphere Entertainment
SPHR
$2.05B
| $2.22M | ﹤0.01% |
50,159
| – | – |
|
1805
Fresh Del Monte Produce
FDP
$1.72B
| $2.22M | ﹤0.01% |
75,000
| – | – |
|
1806
Apogee Therapeutics
APGE
$2.22B
| $2.21M | ﹤0.01% |
37,700
-4,500
| -11% | -$264K |
|
1807
Vita Coco
COCO
$2.22B
| $2.21M | ﹤0.01% |
78,000
| – | – |
|
1808
Scansource
SCSC
$994M
| $2.2M | ﹤0.01% |
45,900
-3,700
| -7% | -$178K |
|
1809
United States Lime & Minerals
USLM
$3.67B
| $2.2M | ﹤0.01% |
22,500
| – | – |
|
1810
Indivior
INDV
$2.98B
| $2.19M | ﹤0.01% |
222,235
-4,407
| -2% | -$43.5K |
|
1811
Encore Capital Group
ECPG
$1.02B
| $2.19M | ﹤0.01% |
46,300
| – | – |
|
1812
Appian
APPN
$2.33B
| $2.19M | ﹤0.01% |
64,100
-6,500
| -9% | -$222K |
|
1813
Monarch Casino & Resort
MCRI
$1.91B
| $2.18M | ﹤0.01% |
27,511
-300
| -1% | -$23.8K |
|
1814
Jamf
JAMF
$1.4B
| $2.18M | ﹤0.01% |
125,500
+25,600
| +26% | +$444K |
|
1815
Interface
TILE
$1.67B
| $2.17M | ﹤0.01% |
114,500
| – | – |
|
1816
MoonLake Immunotherapeutics
MLTX
$3.45B
| $2.17M | ﹤0.01% |
43,000
+12,100
| +39% | +$610K |
|
1817
Applied Digital
APLD
$4.5B
| $2.17M | ﹤0.01% |
+262,500
| New | +$2.17M |
|
|
EVRI
1818
DELISTED
Everi Holdings
EVRI
| $2.17M | ﹤0.01% |
164,800
| – | – |
|
|
PENG
1819
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.37B
| $2.16M | ﹤0.01% |
103,300
+1,000
| +1% | +$21K |
|
1820
Transcat
TRNS
$712M
| $2.16M | ﹤0.01% |
17,915
-100
| -0.6% | -$12.1K |
|
1821
National Beverage
FIZZ
$3.78B
| $2.16M | ﹤0.01% |
46,000
| – | – |
|
|
EFC
1822
Ellington Financial
EFC
$1.35B
| $2.16M | ﹤0.01% |
167,400
| – | – |
|
1823
Avanos Medical
AVNS
$576M
| $2.15M | ﹤0.01% |
89,600
-1,300
| -1% | -$31.2K |
|
1824
PureCycle Technologies
PCT
$2.4B
| $2.15M | ﹤0.01% |
226,500
| – | – |
|
|
LBPH
1825
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.15M | ﹤0.01% |
64,500
+8,300
| +15% | +$277K |
|